Minocycline is an antibiotic that is effective against a number of bacteria types and belongs to the so- called tetracyclines group.
Minocycline Eurogenerics 50 mg is used for the treatment of severe acne with infections (a skin condition).
Werkzame stof(fen) | Minocycline |
Toelatingsland | nl |
Vergunninghouder | Eurogenerics |
ATC-code | J01AA08 |
Farmacologische groepen | Tetracyclines |
Minocycline is an antibiotic that is effective against a number of bacteria types and belongs to the so- called tetracyclines group.
Minocycline Eurogenerics 50 mg is used for the treatment of severe acne with infections (a skin condition).
Do not take Minocycline Eurogenerics if you:
Minocycline must not be administered to children under the age of 8 years.
Warnings and precautions
Talk to your doctor or pharmacist before taking Minocycline Eurogenerics if you:
During the treatment with Minocycline Eurogenerics, talk to your doctor if any of the following occurs:
Taking Minocycline Eurogenerics may cause reduced levels of vitamin B, ascorbic and folic acid and may influence laboratory tests.
Other medicines and Minocycline Eurogenerics
Like other medicines in the same group, Minocycline Eurogenerics 50 mg can cause interactions with many other medicines.
Tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.
An interaction means that medicines or substances can influence each other’s effect(s) and/or side effect(s) when used simultaneously.
An interaction can occur when minocycline is used simultaneously with:
Note: you may be familiar with the above mentioned medicines under another name, often the brand name. In this section only the active substance or the group of active substances of the medicine has been named and not the brand name. You should therefore look carefully at the packaging or in the package leaflet to establish the active substance of the medicine you are using.
Pregnancy, breast-feeding and fertility
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Pregnancy
Minocycline must not be used during pregnancy. The reasons are:
Breastfeeding
Minocycline must not be used when breast-feeding because this can harm the development of the bones and teeth of the child.
Driving and using machines
Minocycline Eurogenerics can cause lightheadedness, visual disturbances, dizziness, ringing in the ears, a feeling of dizziness or spinning (vertigo). Make sure you are not affected before driving or operating machinery.
Minocycline Eurogenerics contains lactose
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
The initial dose is 50 mg every 12 hours. When the infection decreases, the maintenance dose can be reduced to 50 mg once a day or 100 mg every two days.
The acne treatment must be sustained for at least 4 to 6 weeks and preferably no longer than 6 months (see section “Warnings and precautions”).
If the acne does not improve during the first weeks of the treatment, please contact your doctor.
Method of administration
The tablets must be taken when sitting or standing with a large amount of water to avoid irritation of the oesophagus. Do not lie down immediately after taking the tablets. The tablets can be taken during meals and can also be taken with milk if they cause stomach complaints.
If you take more Minocycline Eurogenerics 50 mg than you should
If you take more Minocycline Eurogenerics 50 mg than you should, contact your doctor or pharmacist immediately. In the event of an overdose, the following symptoms can appear: vomiting, attacks of fever, jaundice, bruising, black stools containing blood, and fluid loss. Drink a large amount of water in case of an overdose.
If you forget to take Minocycline Eurogenerics 50 mg
Do not take a double dose to make up for a forgotten dose.
Take the forgotten dose as soon as possible and then abide by the usual schedule. However, if the next dose is due in a few hours, then do not take the forgotten dose and wait until the appropriate time to take the next tablet.
If you stop taking Minocycline Eurogenerics 50 mg
If you suddenly stop, often forget doses or fail to complete the course of treatment, the bacteria causing the infection (and the symptoms of the disease) will multiply again, so that the symptoms of the disease can return or get worse.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Stop taking the tablets immediately and seek urgent medical advice if the following occur:
Tell your doctor if the following side effects occur:
Uncommon side effects (affects 1 to 10 patients in 1,000)
Rare side effects (affects 1 to 10 patients in 10,000)
Very rare side effects (affects less than 1 patient in 10,000)
Other side effects
Other side effects have occurred in a very small number of people but their exact frequency is unknown:
If you get any side effects, talk to your doctor or pharmacist. This includes any side effets not listed in this leaflet.
Keep this medicine out of the sight and reach of children.
Store below 25°C.
Do not use this medicine after the expiry date which is stated on the packaging after “EXP”. The expiry date refers to the last day of that month.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
What Minocycline Eurogenerics contains
- The active substance is minocycline hydrochloride dihydrate.
Minocycline Eurogenerics 50 mg contains 57.93 mg minocycline hydrochloride dihydrate equivalent to 50 mg minocycline base.
- The other ingredients are: povidone K25, lactose monohydrate, microcrystalline cellulose (E460), croscarmellose sodium, colloidal silicon dioxide (E551), magnesium stearate (E470b), hypromellose 2910, Macrogol 6000 (E1521), yellow iron oxide (E172), titanium dioxide (E171).
What Minocycline Eurogenerics looks like and contents of the pack
Minocycline Eurogenerics 50 mg film-coated tablets are light yellow, round, biconvex tablets with a smooth, mat surface.
PVC/PVDC/Aluminium blister packs with 10, 20, 30, 40, 42, 50, 80, 84, 90, 98, 100 film-coated tablets.
Not all pack sizes may be marketed.
Houder van de vergunning voor het in de handel brengen en fabrikanten
Houder van de vergunning voor het in de handel brengen
Eurogenerics NV Heizel Esplanade b22 1020 Brussel
België
Fabrikant
Sanico NV
Veedijk 59
2300 Turnhout
België
Nummer van de vergunning voor het in de handel brengen
RVG 110440
This medicinal product is authorised in the Member States of the EEA under the following names:
BE Minocycline EG 50 mg filmomhulde tabletten LU Minocycline EG 50 mg comprimés pelliculés
NL Minocycline Eurogenerics 50 mg filmomhulde tabletten
Deze bijsluiter is voor het laatst goedgekeurd in november 2012
Laatst bijgewerkt op 24.08.2022
De volgende medicijnen bevatten ook de werkzame stof Minocycline. Raadpleeg uw arts over een mogelijk alternatief voor Minocycline Eurogenerics 50 mg filmomhulde tabletten
Blader hier door onze uitgebreide database van A-Z medicijnen, met effecten, bijwerkingen en doseringen.
Alle actieve ingrediënten met hun werking, toepassing en bijwerkingen, evenals de medicijnen waarin ze zijn opgenomen.
Symptomen, oorzaken en behandeling van veelvoorkomende ziekten en verwondingen.
De weergegeven inhoud vervangt niet de originele bijsluiter van het medicijn, vooral niet met betrekking tot de dosering en werking van de afzonderlijke producten. We kunnen geen aansprakelijkheid aanvaarden voor de nauwkeurigheid van de gegevens, omdat deze gedeeltelijk automatisch zijn omgezet. Raadpleeg altijd een arts voor diagnoses en andere gezondheidsvragen.
© medikamio